Profound Medical (PRN) Scheduled to Post Earnings on Thursday

Profound Medical (TSE:PRN) is scheduled to be posting its quarterly earnings results after the market closes on Thursday, August 8th. Analysts expect the company to announce earnings of C($0.38) per share for the quarter.

Profound Medical (TSE:PRN) last released its quarterly earnings data on Thursday, May 9th. The company reported C($0.35) EPS for the quarter, topping analysts’ consensus estimates of C($0.41) by C$0.06. The firm had revenue of C$2.58 million during the quarter, compared to analysts’ expectations of C$3.24 million.

Profound Medical Stock Down 3.5 %

Shares of TSE:PRN opened at C$13.15 on Wednesday. The stock has a 50-day simple moving average of C$12.45 and a 200-day simple moving average of C$11.61. The stock has a market capitalization of C$321.25 million, a P/E ratio of -7.47 and a beta of 1.27. Profound Medical has a 1 year low of C$9.55 and a 1 year high of C$16.00. The company has a debt-to-equity ratio of 15.78, a quick ratio of 14.98 and a current ratio of 5.41.

Profound Medical Company Profile

Profound Medical Corp., together with its subsidiaries, operates as a commercial-stage medical device company that develops and markets incision-free therapeutic systems for the image guided ablation of diseased tissue in Canada, Germany, the United States, and Finland. Its lead product TULSA-PRO system combines magnetic resonance imaging(MRI), robotically-driven transurethral sweeping action/thermal ultrasound and closed-loop temperature feedback control to provide precise, flexible, and durable ablation of a surgeon defined region of prostate and protect the urethra and rectum.